 |
|
New discovery paves the way for new diagnosis of serious lung disease
March 02, 2009The discovery by Uppsala University researchers of a previously unknown protein in the cells of the lower air ways brings new potential for early diagnosis of a serious lung disease. The findings, published today in the Web edition of the American journal Proceedings of the National Academy of Sciences, can also provide new knowledge of the cause of common diseases like asthma and chronic bronchitis.
Researchers at Uppsala University and Uppsala University Hospital have identified a protein in the lungs that is important to the immune defense system in an autoimmune lung disorder that is not seldom fatal. The newly discovered protein, called KCNRG, occurs in cells in the lower air ways found on the surface of the bronchia. This observation enables researchers to study more closely the first phase of the autoimmune disease, that is, when the immune system erroneously attacks the body's own tissues instead of attacking foreign organisms like bacteria or viruses. The discovery also provides new avenues for developing new diagnostic methods.
The researchers used an unusual hereditary autoimmune disorder, autoimmune polyendocrine syndrome type 1 (APS-1), as a model. Patients with this disease are afflicted by the immune system erroneously attacking several tissues, such as the liver, insulin-producing cells, and adrenal glands.
"Only now have we understood that the lungs are attacked as well and that in many cases this is the most serious component of the disease APS-1," says Dr. Mohammad Alimohammadi.
"It's our hope that the discovery of the protein that the immune system targets, besides making early diagnosis possible, will also be possible to use in understanding the mechanism behind the occurrence of common public health disorders like asthma and chronic bronchitis."
Uppsala University
"Only now have we understood that the lungs are attacked as well and that in many cases this is the most serious component of the disease APS-1," says Dr. Mohammad Alimohammadi.
"It's our hope that the discovery of the protein that the immune system targets, besides making early diagnosis possible, will also be possible to use in understanding the mechanism behind the occurrence of common public health disorders like asthma and chronic bronchitis."
Uppsala University
Lung Disease Current Events and Lung Disease News RSSSurvey: Awareness of COPD is rising, but understanding is still low
Awareness of COPD-chronic obstructive pulmonary disease-continues to grow in the United States, according to national survey results released today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
Multicenter study led by pitt finds early results of therapy for preemies not sustained
Inhaled nitric oxide (iNO), a therapy used in the treatment of premature newborns with respiratory failure that had shown promising results in short-term studies, does not significantly improve long-term outcomes, according to a national study led by critical care researchers at the University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC.
Geneticists Hunt for Scleroderma Triggers
At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them.
Thyroid surgery safe for older patients, study finds
Thyroid surgery is safe for older patients, say physicians who found only slight differences in rates of complications and hospital readmissions in a multi-year study.
Drug could provide first treatment for scleroderma
Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease for which a treatment has remained elusive.
People who work after retiring enjoy better health, according to national study
Retirees who transition from full-time work into a temporary or part-time job experience fewer major diseases and are able to function better day-to-day than people who stop working altogether, according to a national study.
UT scientists discover link between protein and lung disease
In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD).
UAB Researchers Find TB-Prevention Therapy Is Cost-Effective Option
University of Alabama at Birmingham (UAB) researchers have found that the cost of preventive antibiotic tuberculosis (TB) therapy for patients infected by human immunodeficiency virus (HIV) is generally less expensive than the reported cost of treating newly confirmed TB cases.
New vaccine shows promise for COPD patients at risk for pneumonia
A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of the Respiratory and Critical Care Journal, a publication of the American Thoracic Society.
New genes at work in patients with hereditary lung disease
University of Florida researchers have safely given new, functional genes to patients with a hereditary defect that can lead to fatal lung and liver diseases, according to clinical trial findings slated to appear this week in the online early edition of the Proceedings of the National Academy of Sciences.
More Lung Disease Current Events and Lung Disease News Articles
 |
Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide by Robert P. Baughman (Editor), Roberto G. Carbone (Editor), Giovanni Bottino (Editor) Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 150 disorders characterized by scarring or fibrosis of the lungs. In Pulmonary Arterial Hypertension and Interstitial Lung Disease: A Clinical Guide, renowned experts provide a state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. Divided into two sections, the first part provides and update on general issues and introduces both interstitial lung disease and associated pulmonary hypertension. A detailed analysis of the pathology of the various interstitial lung diseases is also provided. The second part addresses specific categories of disease. Bronchiolitis, hypersensitivity pneumonitis, and other conditions are covered, and the use of inspiratory and... |
 |
Diffuse Parenchymal Lung Disease (Progress in Respiratory Research) by U. Costabel (Author), R. M. du Bois (Author), J. J. Egan (Author) Diffuse parenchymal lung disease (DPLD) represents a large and heterogeneous group of disorders. Although new insights into the pathogenesis and new techniques such as high-resolution-CT have led to a better understanding of DPLD, clinical management remains a challenge. This volume is designed to become a valuable aid in the diagnosis and management of DPLD. It starts with general topics such as a new classification system for DPLD, the general diagnostic approach, and clinical evaluation of the patient by radiology, histological patterns and bronchoalveolar lavage. This is followed by consideration of some basic aspects such as the genetics of DPLD, the principles of granuloma formation, pulmonary fibrogenesis and vasculitis, as well as novel treatment approaches. A... |
 |
Sarcoidosis (Lung Biology in Health and Disease) by Robert Baughman (Editor) This reference is the most current and comprehensive source on the many aspects of sarcoidosis, covering topics ranging from the basic science and pathophysiology of the disease to patient evaluation and treatment. It provides a detailed analysis of the pulmonary aspects of the condition and includes chapters on radiographic manifestations, bronchoalveolar lavage research, pulmonary function studies, and proposed markers for the diagnosis and management of the disease. |
 |
Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Lung Biology in Health and Disease) by Nikos Siafakas (Editor), Nicholas R. Anthonisen (Editor), Dimitris Georgopoulos (Editor) Aids practitioners who are looking to more effectively diagnose, treat, and manage patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Discusses pulmonary gas exchange, muscle function and breathing, water/electrolyte imbalances, and end stage disease in AECOPD. |
 |
Pulmonary Hypertension (Lung Biology in Health and Disease) by Marc Humbert (Editor), Joseph P. Lynch III (Editor) Written by internationally recognized experts, Pulmonary Hypertension bridges the gap between pulmonology and cardiology to provide clinicians in both disciplines with knowledge of the signs, symptoms, diagnosis, and pharmacologic and surgical treatments for pulmonary hypertension (PH). Through the use of clinical trials, this ground-breaking text supplies a comprehensive review of both the primary and secondary clinical and investigative aspects of this condition. Discussing controversies and concepts in PH diagnosis and management, this guide explores:
|
|
Dail and Hammar's Pulmonary Pathology: Volume I: Non-neoplastic Lung Disease Volume II: Neoplastic Lung Disease by Philip T. Cagle (Adapter), Carol Farver (Adapter), Armando E. Fraire (Adapter), Joseph F. Tomashefski Jr. (Adapter) Dail and Hammar’s Pulmonary Pathology has established itself as the definitive reference in the field. This third edition is now a two-volume, full color text. Joseph F. Tomashefski, Jr. has led the effort as Editor-in-Chief with the collaboration of Philip T. Cagle, Carol F. Farver, and Armando E. Fraire as Associate Editors. Drs. David H. Dail and Samuel P. Hammar have provided significant contributions to this new edition. The editorial board has continued to build upon the excellence Dail and Hammar achieved in the previous editions by reorganizing, expanding and substantially revising the text. This authoritative reference work has been thoroughly updated to cover newly recognized entities and the latest advances in molecular diagnostic techniques. Abundantly illustrated with... | |
 |
High-Resolution CT of the Lung by W. Richard Webb (Author), Nestor L Müller (Author), David P Naidich (Author) The thoroughly revised Fourth Edition of this widely acclaimed volume explains how to use the newest high-resolution CT technology to detect and diagnose lung abnormalities. Still the only complete text on the topic, this compact, affordable reference is written by the foremost experts and provides cutting-edge technical and clinical information. It includes state-of-the-art HRCT scans of interstitial lung diseases and differential diagnosis tables summarizing the most helpful diagnostic features of interstitial and airspace diseases. This edition includes full-color illustrations of histologic findings in lung disease, correlated with HRCT manifestations. Also included are updated HRCT images obtained on multidetector CT scanners with many coronal and sagittal reformations. Two new... |
|
Interstitial Lung Disease by Marvin I. Schwartz (Author), Talmadge E. King (Author) Aims to provide thorough coverage of the clinical and pathogenic aspects of interstitial lung disease. This edition includes new chapters on imaging techniques, bronchoalveolar lavage, immunology of sarcoidosis and inflammation in interstitial lung disease. | |
 |
Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease, Second Edition (Lung Biology in Health and Disease) by T. Douglas Bradley (Editor), John Floras (Editor) Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease specifically addresses the cardiovascular and cerebrovascular consequences of sleep apnea and is geared toward a broad readership of physicians that will ultimately aid patients suffering from sleep apnea. Key features: STAY UP-TO-DATE-new information on medical research and clinical developments makes this resource a must-read for both clinicians and researchers working in the field OPTIMIZE YOUR DIAGNOSTIC SKILLS-with the latest data on the link between cardiovascular and cerebrovascular consequences of sleep apnea, including clinical trials data IMPROVE TREATMENT AND PATIENT OUTCOMES-with broad coverage of sleep apnea and associated conditions, such as hypertension,... |
 |
Diffuse Lung Disease: A Practical Approach by Robert P. Baughman M.D. (Editor), Roland M. du Bois M.D. (Editor), Joseph P. Lynch M.D. (Editor), Athol U. Wells (Editor) The diagnosis and management of diffuse lung disease (DLD) remain problematic for clinicians, including pulmonologists. Although specific patterns seen in patients may lead quickly to a diagnosis, many patients present with a a constellation of features that is more complex. This book is a practical aid to the physician faced with making a difficult diagnoses in their own clinical setting. It opens with an introductory section coevring general considerations-patient evaluation, including history and clinical signs, investigations, DLD classification according to the current guidelines, and therapeutic options. This is followed by a section devoted to specific DLDs including sarcoidosis, idiopathic pulmonary fibrosis, occupational and iatrogenic DLDs, and other less common disorders.... |
| © 2009 BrightSurf.com |